# David P. Nicolau

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/david-p-nicolau/

## Facts

| Field | Value |
| --- | --- |
| Citations | 24,540 |
| Field | Antibiotics Pharmacokinetics and Efficacy |
| h-index | 72 |
| i10-index | 536 |
| Last Known Institution | NKT Therapeutics (United States) |
| OpenAlex ID | https://openalex.org/A5090740872 |
| ORCID iD | https://orcid.org/0000-0002-4148-0165 |
| Works | 912 |

## Researcher papers

- [Randomized, Open-Label, Comparative Study of Piperacillin-Tazobactam Administered by Continuous Infusion versus Intermittent Infusion for Treatment of Hospitalized Patients with Complicated Intra-Abdominal Infection](https://scholariq.org/papers/randomized-open-label-comparative-study-of-piperacillin-tazobactam-administered/)

## Researcher topics

- [Antibiotics Pharmacokinetics and Efficacy](https://scholariq.org/topics/antibiotics-pharmacokinetics-and-efficacy/)
- [Antibiotic Resistance in Bacteria](https://scholariq.org/topics/antibiotic-resistance-in-bacteria/)
- [Pneumonia and Respiratory Infections](https://scholariq.org/topics/pneumonia-and-respiratory-infections/)
- [Antibiotic Use and Resistance](https://scholariq.org/topics/antibiotic-use-and-resistance/)
- [Antimicrobial Resistance in Staphylococcus](https://scholariq.org/topics/antimicrobial-resistance-in-staphylococcus/)

## Researcher university

- [NKT Therapeutics (United States)](https://scholariq.org/institutions/nkt-therapeutics-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.